Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nature

• Publication date

  2001-05-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/35078107PMID 11373684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RNA interference is mediated by 21- and 22-nucleotide RNAs.

  2001cited by this paper
• Ribosomal peptidyl transferase can withstand mutations at the putative catalytic nucleotide

  2001cited by this paper
• RNA interference--2001.

  2001cited by this paper
• Replicating satellite RNA induces sequence-specific DNA methylation and truncated transcripts in plants.

  2001cited by this paper
• Role for a bidentate ribonuclease in the initiation step of RNA interference

  2001cited by this paper
• Post-transcriptional gene silencing by double-stranded RNA

  2001cited by this paper
• RNA Interference and Small Interfering RNAs

  2001cited by this paper
• B cells extract and present immobilized antigen: implications for affinity discrimination

  2000cited by this paper
• Specific interference with gene function by double-stranded RNA in early mouse development

  2000cited by this paper
• Variation in the reversibility of evolution

  2000cited by this paper
• RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals.

  2000cited by this paper
• Entry of B Cell Receptor into Signaling Domains Is Inhibited in Tolerant B Cells

  2000cited by this paper
• T Cells Can Use Either T Cell Receptor or Cd28 Receptors to Absorb and Internalize Cell Surface Molecules Derived from Antigen-Presenting Cells

  2000cited by this paper
• Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes.

  2000cited by this paper
• RNA-directed DNA methylation

  2000cited by this paper
• dsRNA-mediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference.

  2000cited by this paper
• Sensitive assay of RNA interference in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target

  2000cited by this paper
• Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways.

  2000cited by this paper
• Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference.

  2000cited by this paper
• Inhibition of hepatitis C virus (HCV)‐RNA–dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes

  2000cited by this paper
• Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference.

  2000cited by this paper
• Monomeric and oligomeric complexes of the B cell antigen receptor.

  2000cited by this paper
• Transcriptional silencing and promoter methylation triggered by double‐stranded RNA

  2000cited by this paper
• An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells

  2000cited by this paper
• The immunological synapse: a molecular machine controlling T cell activation.

  1999cited by this paper
• RNA-triggered gene silencing.

  1999cited by this paper
• Guidebook to cytoskeletal and motor proteins

  1999cited by this paper
• A Role for Lipid Rafts in B Cell Antigen Receptor Signaling and Antigen Targeting

  1999cited by this paper
• TCR-Mediated internalization of peptide-MHC complexes acquired by T cells.

  1999cited by this paper
• Loss of a-Type Lamin Expression Compromises Nuclear Envelope Integrity Leading to Muscular Dystrophy

  1999cited by this paper
• A species of small antisense RNA in posttranscriptional gene silencing in plants.

  1999cited by this paper
• Transcriptional and Posttranscriptional Silencing of Rodent α1(I) Collagen by a Homologous Transcriptionally Self-Silenced Transgene

  1999cited by this paper
• Self assembly of NuMA: multiarm oligomers as structural units of a nuclear lattice

  1999cited by this paper
• Three-dimensional segregation of supramolecular activation clusters in T cells

  1998cited by this paper
• Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes.

  1998cited by this paper
• Nucleocytoplasmic Shuttling Factors Including Ran and CRM1 Mediate Nuclear Export of NFAT In Vitro

  1998cited by this paper
• CpG methylation, chromatin structure and gene silencing—a three‐way connection

  1998cited by this paper
• Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate.

  1998cited by this paper
• A receptor/cytoskeletal movement triggered by costimulation during T cell activation.

  1998cited by this paper
• How cells respond to interferons.

  1998cited by this paper
• Acceleration of intracellular targeting of antigen by the B‐cell antigen receptor: importance depends on the nature of the antigen–antibody interaction

  1997cited by this paper
• B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen

  1996cited by this paper
• Serial triggering of many T-cell receptors by a few peptide–MHC complexes

  1995cited by this paper
• Follicular dendritic cells help resting B cells to become effective antigen-presenting cells: induction of B7/BB1 and upregulation of major histocompatibility complex class II molecules

  1993cited by this paper
• Interactions between double-stranded RNA regulators and the protein kinase DAI

  1992cited by this paper
• The bride of sevenless and sevenless interaction: internalization of a transmembrane ligand.

  1992cited by this paper
• Peripheral deletion of self-reactive B cells

  1991cited by this paper
• Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens

  1991cited by this paper
• Follicular Dendritic Cells as Accessory Cells

  1990cited by this paper
• Induction of nuclear lamins A/C in macrophages in in vitro cultures of rat bone marrow precursor cells and human blood monocytes, and in macrophages elicited in vivo by thioglycollate stimulation.

  1990cited by this paper
• Transformation of growth factor-dependent myeloid stem cells with retroviral vectors carrying c-myc.

  1989cited by this paper
• Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes

  1989cited by this paper
• Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice

  1988cited by this paper
• Anti-immunoglobulin augments the B-cell antigen-presentation function independently of internalization of receptor-antigen complex.

  1985cited by this paper
• The Follicular Dendritic Cell: Its Role in Antigen Presentation in the Generation of Immunological Memory

  1980cited by this paper
• Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells.

  1979cited by this paper
• Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.

  1978cited by this paper
• Capping and the lymphocyte: models for membrane reorganization.

  1977cited by this paper
• Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody.

  1971cited by this paper
• Nonlinear limits to the information capacity of optical ® bre communications

  year unknowncited by this paper

• PIWI-interacting RNA-ame-1128833 targets honeybee Yes-associated protein 1 (AmYAP1) to modulate gut growth and developmental gene expression in honeybee larvae.

  2026cites this paper
• DsRNA as pathogen-associated molecular pattern in innate immunity and multiple functions of the RNAi machinery complicate the use of RNAi in pest control

  2026cites this paper
• Delivery of siRNA and Chloroquine Through an Aspherical, Nanostructured Microparticle for Passive Targeting of Alveolar Macrophages and Inhibition of Local TNF-α Secretion.

  2026cites this paper
• Annotating genomes at increased scale and resolution.

  2026cites this paper
• Navigating the next frontier in biomedicine: breakthroughs and insights in nucleic acid therapeutics

  2026cites this paper
• Exploring Conformational Transitions of RNA Dimers via Machine Learning Potentials

  2026cites this paper
• Organyl 5′‑Phosphates in siRNA Guide Strands: Structure–Function Relationships Governing Anchoring in Argonaute 2 and Metabolic Stability

  2026cites this paper
• Control Strategies of Plant Viruses Using Spray-Induced Gene Silencing

  2026cites this paper
• RNA-Based Therapies for Treating Monogenic Cardiomyopathies.

  2026cites this paper
• 2′-Ribose-modified nucleotides: A strategy for reducing off-target effects of oligonucleotide drugs

  2026cites this paper
• Recent advances in factor XII(a) inhibitors: an updated patent landscape (2020-present).

  2026cites this paper
• siRNA-based nanotherapeutics for malignant and non-malignant diffuse parenchymal lung diseases

  2026cites this paper
• Nucleic acid based therapies - the next frontier in treating dyslipidemias.

  2026cites this paper
• Gene therapy for huntington’s disease: advances, challenges, and future perspectives

  2026cites this paper
• Post-transcriptional regulation in intervertebral disc degeneration

  2026cites this paper
• Validating Interpretability in siRNA Efficacy Prediction: A Perturbation-Based, Dataset-Aware Protocol

  2026cites this paper
• Polarity- and Sequence-Dependent Ionization of Therapeutic Antibody-siRNA Conjugates: Enabling Intact Multi-attribute Method for Comprehensive Characterization and Identity Release Assay.

  2026cites this paper
• Emerging Oligonucleotide Therapeutics for the Treatment of Dry Eye Diseases

  2026cites this paper
• Precision nanomedicine in cardiovascular disease: Engineered siRNA delivery platforms for atherosclerosis and ischemic heart disease

  2026cites this paper
• Presence of phosphodiester backbone, but not nucleobases, in the guide’s 3′ terminal region is necessary for RISC loading and target cleavage in vitro and in vivo

  2026cites this paper
• Chemical biology of precise RNA targeting and intervention: advances and perspectives

  2026cites this paper
• Controllable targeted protein degradation as a promising tool for discovery of novel cellular and developmental mechanisms.

  2025cites this paper
• A Novel Hybrid LC-MS/MS Methodology for the Quantitative Bioanalysis of Antibody-siRNA Conjugates

  2025cites this paper
• New Therapeutic Modalities in Prion Diseases.

  2025cites this paper
• Beyond Liquid Chromatography: Cyclic Ion Mobility Spectrometry for Phosphorothioate Diastereomer Separation in siRNA.

  2025cites this paper
• Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy

  2025cites this paper
• The Antiangiogenic Effect of VEGF-A siRNA-FAM-Loaded Exosomes

  2025cites this paper
• Overcoming platinum-resistant ovarian cancer targeting the activated JAK-STAT pathways via extracellular vesicles

  2025cites this paper
• RNA Therapeutics: Bridging Discovery and Clinical Implementation.

  2025cites this paper
• Redox-cleavable disulfide linker enhances siRNA delivery by prodrug-type bifunctional cell-penetrating peptide.

  2025cites this paper
• Lysozyme Amyloid for Synthetic RNA Delivery

  2025cites this paper
• Monoclonal Protein Evaluation in the Diagnostic Algorithm for Cardiac Amyloidosis

  2025cites this paper
• Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration—A Comprehensive Review

  2025cites this paper
• Intracellular fatty acid levels differentially impact target silencing by FDA-approved siRNA drugs.

  2025cites this paper
• RNA drugs and nonviral nanocarriers in oncology - present status and emerging concepts.

  2025cites this paper
• Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Its Implications for Prophylactic and Therapeutic Pharmaceuticals

  2025cites this paper
• Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases

  2025cites this paper
• Chemically modified non-coding RNAs in cancer

  2025cites this paper
• NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicines

  2025cites this paper
• Comparative analysis of convergent and divergent T7 RNA polymerase promoters for the synthesis of dsRNA in vivo and in vitro

  2025cites this paper
• Application of nanotechnology and micro/nanorobots in thrombotic diseases

  2025cites this paper
• The magic bullet: a tribute to Fritz Eckstein

  2025cites this paper
• Optimizing siRNA Therapeutics Targeting HIF-1α: Computational Design, Screening, and Molecular Dynamics Simulation Studies.

  2025cites this paper
• RNA Through Time: From the Origin of Life to Therapeutic Frontiers in Transcriptomics and Epitranscriptional Medicine

  2025cites this paper
• Emerging Insights into Granulomatous and Amyloidogenic Cardiomyopathies

  2025cites this paper
• Cationic lipopolymer based siRNA delivery for experimental lung cancer treatment.

  2025cites this paper
• Therapeutic Approaches of Viral Gene Silencing by Small Interfering RNA: Strategies to Prevent the Emergence of Antiviral Resistant Escape Mutants

  2025cites this paper
• Photothermal Therapeutic Gold Nanoparticles Loaded with PD-L1 siRNA Enhanced Killing of NSCLC Cells by Immune Cells

  2025cites this paper
• DNA repair at the crossroads of tumor immunogenicity and cancer therapy: Harnessing innate and adaptive immune pathways for improved therapeutic outcomes.

  2025cites this paper
• Small Interfering RNAs Targeting VP4, VP3, 2B, or 3A Coding Regions of Enterovirus A71 Inhibit Viral Replication In Vitro

  2025cites this paper
• Transcriptional regulation as a dose-dependent process: insights from transcription factor tuning

  2025cites this paper
• The impact of ncRNAs on type 2 diabetes: A comprehensive review covering molecular mechanisms to clinical applications

  2025cites this paper
• Allele-specific depletion of GNAQQ209L via siRNA or an rAAV2-shRNA vector induces selective toxicity in GNAQQ209L uveal melanoma cells

  2025cites this paper
• 3'-C-Extended TNA: De Novo Synthesis, Enhanced Exonuclease Resistance, and Functional siRNA 3'-Overhang Modifications Without Compromising Gene Silencing.

  2025cites this paper
• A bioinformatic ecological risk assessment framework for externally applied dsRNA-based biopesticides.

  2025cites this paper
• siRNA nanodelivery systems in the treatment of skin Diseases: Research progress and clinical translation prospects.

  2025cites this paper
• RNA silencing suppression in plant pathogens: mechanism and function in disease pathology

  2025cites this paper
• Molecular dynamics simulations based siRNA design against GPR10 reveals stable RNAi therapeutics for hormone-dependent uterine fibroids

  2025cites this paper
• Bioinspired Extracellular Vesicles for Enhanced Delivery of siRNA to Tumors.

  2025cites this paper
• Chemical Strategies to Enhance Antisense Strand Selection and Minimize Off-Target Effect-Mediated by siRNAs.

  2025cites this paper
• siRMSD: A Structural Parameter to Reduce Sequence-Dependent Off-Target Effects for siRNA Design with Chemical Modifications.

  2025cites this paper
• Chemical Modifications in Nucleic Acid Therapeutics.

  2025cites this paper
• Current Trends in Gene Therapy to Treat Inherited Disorders of the Brain.

  2025cites this paper
• Tumor-Selective Gene Therapy: Using Hairpin DNA Oligonucleotides to Trigger Cleavage of Target RNA by Endogenous flap endonuclease 1 (FEN 1) Highly Expressed in Tumor Cells.

  2025cites this paper
• Systemic toxicity and toxicokinetics study of self-assembled-micelle inhibitory RNA-targeting amphiregulin in cynomolgus monkeys following intravenous injection

  2025cites this paper
• siRNA-guided dual-targeting nanocarrier for breast cancer treatment

  2025cites this paper
• Advances in Therapeutic Applications of CRISPR Genome Editing for Spinal Pain Management

  2025cites this paper
• Dicer-like genes are essential for efficient plant infection in the rubber tree powdery mildew fungus Erysiphe quercicola.

  2025cites this paper
• Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines

  2025cites this paper
• Immunoengineering of a Photocaged 5´‐triphosphate Oligoribonucleotide Ligand for Spatiotemporal Control of RIG‐I Activation in Cancer

  2025cites this paper
• RNA methyltransferase SPOUT1/CENP-32 links mitotic spindle organization with the neurodevelopmental disorder SpADMiSS

  2025cites this paper
• Nanoscale strategies: doxorubicin resistance challenges and enhancing cancer therapy with advanced nanotechnological approaches

  2025cites this paper
• RNA research for drug discovery: Recent advances and critical insight.

  2025cites this paper
• Comprehensive dissection of cis-regulatory elements in a 2.8 Mb topologically associated domain in six human cancers

  2025cites this paper
• Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models – a comprehensive review

  2025cites this paper
• Genetic circuits in synthetic biology: broadening the toolbox of regulatory devices

  2025cites this paper
• Next-Gen Cancer Treatment: Nanotechnology-Driven siRNA Delivery Solutions

  2025cites this paper
• Carboxymethyl Dextran-Based Drug Delivery Systems: Advances, Challenges, and Applications in Cancer Therapy

  2025cites this paper
• Targeted melanoma therapy: High-efficiency siRNA delivery with R8-PEI dissolvable microneedles.

  2025cites this paper
• Advances in the screening, diagnosis, and treatment of transthyretin amyloid cardiomyopathy: New insights and future directions.

  2025cites this paper
• A Robust siRNA Screening Approach with Optimized Conditions for Large-Scale Transfection in Multiple Human Cancer Cell Lines.

  2025cites this paper
• Bundling gold nanorods with RCA-produced DNA tape into an intelligently reconfigurable nanocluster bomb for multimodal precision cancer therapy

  2025cites this paper
• Click Conjugates of Artificial Ribonucleases: Sequence Specific Cleavage with Multiple Turnover

  2025cites this paper
• Gene Therapy Drugs Based on Synthetic Oligonucleotides

  2025cites this paper
• Synthetic Polymers for Drug, Gene, and Vaccine Delivery

  2025cites this paper
• Formulation of siRNA nanoparticles, transfection and enhanced adhesion -penetration in nasal mucosal tissue.

  2025cites this paper
• MicroRNA for Post-Transcriptional Regulation of Gene Expression: 2024 Nobel Prize in Physiology or Medicine

  2025cites this paper
• Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems.

  2025cites this paper
• Advances in biomaterials and regenerative medicine for diabetic foot ulcer therapy.

  2025cites this paper
• Stimuli-responsive peptide nanocarriers for tumor-specific CRISPR/Cas9 delivery and precision genome editing.

  2025cites this paper
• Realizing the therapeutic potential of rapid knockdown of transthyretin via RNA interference in transthyretin amyloidosis

  2025cites this paper
• Unveiling the translational and therapeutic potential of small interfering RNA molecules in combating SARS-CoV-2: A review.

  2025cites this paper
• Expanded gene targeting in RNA hacking with G-tract-supply Staple oligomer

  2025cites this paper
• MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma

  2025cites this paper
• A side-by-side comparison of variant function measurements using deep mutational scanning and base editing

  2025cites this paper
• A Double‐Blind, Placebo‐Controlled, Single‐Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT‐101, an RNAi Therapeutic Targeting HBV Infection

  2025cites this paper
• METTL16 in cancer: Roles and regulatory mechanisms

  2025cites this paper
• Spatially Coordinated Delivery of siRNA and Peptide Antagonist by Using Quantum Dots for Synergetic Cancer Therapy.

  2025cites this paper
• Effects of acid-mediated deamination of cytidine and 5-methylcytidine on solid-phase synthesis of oligonucleotides

  2025cites this paper
• Sulfasalazine-double stranded ribonucleic acid nanoparticle for controlling Aedes aegypti mosquitoes.

  2025cites this paper